FDA approves SORILUX for adolescent plaque psoriasis

07:31 EDT 23 May 2019 | Pharmaceutical Business Review

SORILUX is now approved for treating plaque psoriasis of the scalp and body in patients aged 12 years and older. The FDA approved SORILUX in 2010 based on

The post FDA approves SORILUX for adolescent plaque psoriasis appeared first on Pharmaceutical Business review.

Original Article: FDA approves SORILUX for adolescent plaque psoriasis

More From BioPortfolio on "FDA approves SORILUX for adolescent plaque psoriasis"